Results
21,218 records
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 43 | Duffy Sean P.Director, Chief Executive Officer |  OMDAOmada Health, Inc.Open-market sale | SELL | $2.15M 140.0K sh | Jan 14, 2026 traded Jan 12, 2026 | |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 43 | Duffy Sean P.Director, Chief Executive Officer | OMDAOmada Health, Inc. Open-market sale | SELL | $2.15M 140.0K sh | Jan 14, 2026 traded Jan 12, 2026 | |
Myles David C.CH. DISCOV. & NON-CLIN DEV OFF |
 OLMAOlema Pharmaceuticals, Inc.Open-market sale |
| SELL |
| $1.37M 49.8K sh |
| Jan 14, 2026 traded Jan 13, 2026 |
| 39 | Garg PushkalEVP Chief R&D |  ALNYALNYLAM PHARMACEUTICALS, INC.Open-market sale | SELL | $56K 155 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Garg PushkalEVP Chief R&D | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $80K 220 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Janks Leon CDirector |  PSMTPRICESMART INCOpen-market sale | SELL | $207K 1,501 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $133K 365 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $56K 156 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $65K 181 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Tanguler TolgaEVP, Chief Commercial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $56K 155 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $102K 284 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Tanguler TolgaEVP, Chief Commercial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $80K 220 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Tanguler TolgaEVP, Chief Commercial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $73K 199 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $63K 170 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Garg PushkalEVP Chief R&D | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $73K 199 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Janks Leon CDirector | PSMTPRICESMART INC Open-market sale | SELL | $205K 1,499 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Bricker JudeDirector, Chief Executive Officer |  SNCYSun Country Airlines Holdings, Inc.Open-market sale | SELL | $89K 5,062 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Frank MalcolmDirector |  FDSFACTSET RESEARCH SYSTEMS INCOpen-market sale | SELL | $452K 1,527 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $81K 226 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $148K 405 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $63K 176 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 38 | Allison EricChief Product Officer |  JOBYJoby Aviation, Inc.Open-market sale | SELL | $319K 21.5K sh | Jan 14, 2026 traded Jan 13, 2026 |
| 37 | Soule Randy10% Owner |  SAFXXCF Global, Inc.Open-market sale | SELL | $34K 200.0K sh | Jan 14, 2026 traded Jan 8, 2026 |
| 37 | Myles David C.CH. DISCOV. & NON-CLIN DEV OFF | OLMAOlema Pharmaceuticals, Inc. Open-market sale | SELL | $1.01M 35.0K sh | Jan 14, 2026 traded Jan 14, 2026 |
| 37 | Myles David C.CH. DISCOV. & NON-CLIN DEV OFF | OLMAOlema Pharmaceuticals, Inc. Open-market sale | SELL | $283K 10.0K sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | McBee BranninChief Development Officer |  CRWVCoreWeave, Inc.Open-market sale · 10b5-1 plan | SELL | $387K 4,240 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Bevirt JoeBenDirector, CEO and Chief Architect, 10% Owner | JOBYJoby Aviation, Inc. Open-market sale | SELL | $24K 1,630 sh | Jan 14, 2026 traded Jan 13, 2026 |
| 36 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $34K 92 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Garg PushkalEVP Chief R&D | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $15K 40 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Tanguler TolgaEVP, Chief Commercial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $34K 92 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Snow Colton MatthewSVP, Chief Commercial Officer | SNCYSun Country Airlines Holdings, Inc. Open-market sale | SELL | $13K 759 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Tanguler TolgaEVP, Chief Commercial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $34K 96 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Tanguler TolgaEVP, Chief Commercial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $17K 47 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Tanguler TolgaEVP, Chief Commercial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $18K 50 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Garg PushkalEVP Chief R&D | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $17K 47 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Tanguler TolgaEVP, Chief Commercial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $14K 39 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $49K 135 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Garg PushkalEVP Chief R&D | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $34K 96 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Tanguler TolgaEVP, Chief Commercial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $26K 73 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $387K 4,240 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $13K 36 sh | Jan 14, 2026 traded Jan 12, 2026 |